Peripheral neuropathy (PN) was observed in 26% (2% at grade 3–4) and 42% (6% at grade 3–4) of patients who received PV‐R‐CHP and R‐CHOP, respectively. This evidence concerns the gene DDIT3 and poikiloderma with neutropenia.